1. Home
  2. BMRN
  3. BMRN News

Latest BioMarin Pharmaceutical Inc. (BMRN) News on July 26, 2024

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
BMRN

Zacks

9 hours ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

FDA agrees wider use of BioMarin’s BRINEURA for CLN2
BMRN

Pharmaceutical Technology

2 days ago

FDA agrees wider use of BioMarin’s BRINEURA for CLN2

BMRN

MT Newswires

2 days ago

BioMarin Pharmaceutical Gets FDA Nod for Supplemental BLA to Slow Ambulation Loss in Tripeptidyl Peptidase 1 Deficiency

U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
BMRN

PR Newswire

2 days ago

U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease

Why BioMarin (BMRN) is Poised to Beat Earnings Estimates Again
BMRN

Zacks

2 days ago

Why BioMarin (BMRN) is Poised to Beat Earnings Estimates Again

BMRN

Argus Research

3 days ago

BMRN: Lowering target price to $68.00

Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
BMRN

Zacks

3 days ago

Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for

BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET
BMRN

PR Newswire

3 days ago

BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release
BMRN

Zacks

4 days ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
BMRN

Zacks

9 days ago

Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?

BMRN

Argus Research

10 days ago

BMRN: Raising target price to $69.00

Is The Options Market Predicting A Spike In BioMarin Pharmaceutical (BMRN) Stock?
BMRN

Zacks

11 days ago

Is The Options Market Predicting A Spike In BioMarin Pharmaceutical (BMRN) Stock?

Three US Stocks Estimated To Be Trading Below Their Intrinsic Values In July 2024
BMRN

Simply Wall St.

15 days ago

Three US Stocks Estimated To Be Trading Below Their Intrinsic Values In July 2024

BMRN

Argus Research

17 days ago

BMRN: Lowering target price to $66.00

Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
BMRN

Insider Monkey

25 days ago

Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)

BMRN

MT Newswires

a month ago

Wells Fargo Adjusts BioMarin Pharmaceutical Price Target to $115 From $110, Maintains Overweight Rating

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate
BMRN

Simply Wall St.

a month ago

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate

Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
BMRN

Insider Monkey

a month ago

Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?

Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
BMRN

Zacks

a month ago

Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?

BioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children's Bone Health
BMRN

PR Newswire

a month ago

BioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children's Bone Health

BMRN

Morningstar Research

a month ago

Analyst Report: BioMarin Pharmaceutical Inc.

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
BMRN

PR Newswire

2 months ago

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

BMRN

MT Newswires

2 months ago

BioMarin Pharmaceutical Reports New Data Affirming Long-Term Safety, Efficacy of Roctavian

BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress
BMRN

PR Newswire

2 months ago

BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress

BridgeBio data show sustained benefit for achondroplasia drug
BMRN

BioPharma Dive

2 months ago

BridgeBio data show sustained benefit for achondroplasia drug

BMRN

MT Newswires

2 months ago

BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing

BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the stock a year ago
BMRN

Simply Wall St.

2 months ago

BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the stock a year ago

BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?
BMRN

Zacks

2 months ago

BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?

4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
BMRN

Motley Fool

2 months ago

4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
BMRN

BioPharma Dive

2 months ago

Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170

BMRN

MT Newswires

2 months ago

Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
BMRN

PR Newswire

3 months ago

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV

Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
BMRN

Zacks

3 months ago

Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand

Insider Sale: EVP, Chief Commercial Officer Jeffrey Ajer Sells 5,000 Shares of Biomarin ...
BMRN

GuruFocus.com

3 months ago

Insider Sale: EVP, Chief Commercial Officer Jeffrey Ajer Sells 5,000 Shares of Biomarin ...

BMRN

MT Newswires

3 months ago

Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing

5 Biotech Stocks Worth Adding to Your Portfolio in 2024
BMRN

Zacks

3 months ago

5 Biotech Stocks Worth Adding to Your Portfolio in 2024

New Data for BioMarin's VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting
BMRN

PR Newswire

3 months ago

New Data for BioMarin's VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting

BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
BMRN

Simply Wall St.

3 months ago

BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

BMRN

MT Newswires

3 months ago

BioMarin Pharmaceutical Investors Overfocused on Roctavian, Distracted From Enzyme Replacement Therapies, UBS Says

4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
BMRN

Motley Fool

3 months ago

4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
BMRN

GuruFocus.com

3 months ago

Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BMRN

Insider Monkey

3 months ago

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript

BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
BMRN

Simply Wall St.

3 months ago

BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations

Pfizer hemophilia gene therapy arrives in US to uncertain future
BMRN

BioPharma Dive

3 months ago

Pfizer hemophilia gene therapy arrives in US to uncertain future

BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
BMRN

Zacks

3 months ago

BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales

BMRN

MT Newswires

3 months ago

Scotiabank Adjusts Price Target on BioMarin Pharmaceutical to $85 From $83, Maintains Sector Perform Rating

BMRN

Morningstar Research

3 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

BMRN

MT Newswires

3 months ago

Wells Fargo Adjusts Price Target on BioMarin Pharmaceutical to $110 From $100, Maintains Overweight Rating

BioMarin drops drug programs in pipeline cull
BMRN

BioPharma Dive

3 months ago

BioMarin drops drug programs in pipeline cull

BMRN

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Biomarin Pharmaceutical Inc Earnings Call

BMRN

GuruFocus.com

3 months ago

Biomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ...

BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
BMRN

Zacks

3 months ago

BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

BMRN

GuruFocus.com

3 months ago

BioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimates

BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
BMRN

Zacks

3 months ago

BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates

BMRN

MT Newswires

3 months ago

BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours

BMRN

Associated Press Finance

3 months ago

BioMarin: Q1 Earnings Snapshot

BioMarin Reports Record Financial Results for the First Quarter 2024
BMRN

PR Newswire

3 months ago

BioMarin Reports Record Financial Results for the First Quarter 2024

Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
BMRN

Zacks

3 months ago

Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?

AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
BMRN

Zacks

3 months ago

AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect

BMRN

MT Newswires

3 months ago

BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says

Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
BMRN

Zacks

3 months ago

Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics

Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
BMRN

Zacks

3 months ago

Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline

BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
BMRN

Zacks

3 months ago

BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?

Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
BMRN

GuruFocus.com

3 months ago

Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...

BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
BMRN

PR Newswire

4 months ago

BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET

Insider Sell: EVP, Chief Legal Officer George Davis Sells 24,602 Shares of Biomarin ...
BMRN

GuruFocus.com

4 months ago

Insider Sell: EVP, Chief Legal Officer George Davis Sells 24,602 Shares of Biomarin ...

Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?
BMRN

Zacks

4 months ago

Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?

4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
BMRN

Motley Fool

4 months ago

4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
BMRN

PR Newswire

4 months ago

New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
BMRN

GuruFocus.com

5 months ago

BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth

Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ...
BMRN

GuruFocus.com

5 months ago

Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ...

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
BMRN

PR Newswire

5 months ago

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer

BioMarin Scheduled to Participate in March Investor Conferences
BMRN

PR Newswire

5 months ago

BioMarin Scheduled to Participate in March Investor Conferences

Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight
BMRN

GuruFocus.com

5 months ago

Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight

BMRN

Reuters

5 months ago

REFILE-UPDATE 2-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies

BMRN

Reuters

5 months ago

REFILE-BioMarin Pharma gets DOJ subpoena on certain drug testing programs

BioMarin Pharmaceutical Full Year 2023 Earnings: EPS: US$0.89 (vs US$0.76 in FY 2022)
BMRN

Simply Wall St.

5 months ago

BioMarin Pharmaceutical Full Year 2023 Earnings: EPS: US$0.89 (vs US$0.76 in FY 2022)

BMRN

Morningstar Research

5 months ago

Analyst Report: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
BMRN

Insider Monkey

5 months ago

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript

BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
BMRN

Zacks

5 months ago

BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales

BMRN

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Biomarin Pharmaceutical Inc Earnings Call

20 Fastest Growing Biotech Companies in the US
BMRN

Insider Monkey

5 months ago

20 Fastest Growing Biotech Companies in the US

BioMarin preaches patience amid slow sales for hemophilia gene therapy
BMRN

BioPharma Dive

5 months ago

BioMarin preaches patience amid slow sales for hemophilia gene therapy

Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings
BMRN

Zacks

5 months ago

Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings

BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
BMRN

Zacks

5 months ago

BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates

BioMarin Pharmaceutical Inc. (BMRN) Announces Record Financial Results for 2023
BMRN

GuruFocus.com

5 months ago

BioMarin Pharmaceutical Inc. (BMRN) Announces Record Financial Results for 2023

BMRN

Associated Press Finance

5 months ago

BioMarin: Q4 Earnings Snapshot

BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
BMRN

PR Newswire

5 months ago

BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024

5 Stocks Likely to Gain on Q4 Earnings Today After Market Close
BMRN

Zacks

5 months ago

5 Stocks Likely to Gain on Q4 Earnings Today After Market Close

Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More
BMRN

Zacks

5 months ago

Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More

Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
BMRN

Zacks

5 months ago

Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Seeking Clues to BioMarin (BMRN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
BMRN

Zacks

5 months ago

Seeking Clues to BioMarin (BMRN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?
BMRN

Zacks

5 months ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?

5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
BMRN

Zacks

5 months ago

5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates

PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc
BMRN

GuruFocus.com

5 months ago

PRIMECAP Management Bolsters Stake in Biomarin Pharmaceutical Inc

7 Biotech Stocks Fighting America’s Deadliest Diseases
BMRN

InvestorPlace

6 months ago

7 Biotech Stocks Fighting America’s Deadliest Diseases

BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET
BMRN

PR Newswire

6 months ago

BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET

3 No-Brainer Stocks to Buy With $200 Right Now
BMRN

Motley Fool

6 months ago

3 No-Brainer Stocks to Buy With $200 Right Now

BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) Congress
BMRN

PR Newswire

6 months ago

BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) Congress

Snowflake, Datadog, Cloud Software Stocks Lifted By Amazon, Microsoft Reports
BMRN

Investor's Business Daily

6 months ago

Snowflake, Datadog, Cloud Software Stocks Lifted By Amazon, Microsoft Reports

Share on Social Networks: